National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Department of Exercise and Nutrition Sciences, George Washington University, Washington, District of Columbia.
Am J Perinatol. 2023 Sep;40(12):1286-1291. doi: 10.1055/s-0041-1735555. Epub 2021 Sep 9.
This study aimed to investigate human fetal exposure to non-nutritive sweeteners (NNS) by analyzing amniotic fluid and umbilical cord blood.
Concentrations of four NNS (acesulfame-potassium [ace-K], saccharin, steviol glucuronide, and sucralose) were measured in amniotic fluid ( = 13) and cord blood samples ( = 15) using liquid chromatography-mass spectrometry. Amniotic fluid samples were obtained for research purposes at the time of term elective cesarean birth or clinically indicated third trimester amnioreduction at Mercy Hospital for Women (Melbourne, Australia). All except four women were in the fasting state. Cord blood samples were obtained from an independent cohort of newborns whose mothers were enrolled in a separate clinical trial at the National Institutes of Health.
Ten of 13 amniotic fluid samples contained at least one NNS (ace-K, saccharin, steviol glucuronide, and/or sucralose). Maximum amniotic fluid NNS concentrations of ace-K, saccharin, steviol glucuronide, and sucralose were 78.9, 55.9, 93.5, and 30.6 ng/mL, respectively. Ace-K and saccharin were present in 100% and 80% of the cord blood samples, with maximal concentrations of 6.5 and 2.7 ng/mL, respectively. Sucralose was not detected and steviol glucuronide was not measurable in any of the cord blood samples.
Our results provide evidence of human transplacental transmission of NNS. Based on results predominantly obtained from rodent models, we speculate that NNS exposure may adversely influence the offsprings' metabolic health. Well-designed, prospective clinical trials are necessary to understand the impact of NNS intake during pregnancy on human development and long-term health.
· NNS consumption during pregnancy has increased in recent years.. · Maternal NNS intake during pregnancy is associated with preterm birth and higher infant weight gain in epidemiologic studies.. · In rodents, in utero NNS exposure induces metabolic abnormalities in mothers and their offspring, alters offspring gut microbiota composition, and promotes sweet taste preference in adulthood.. · It is presently unknown whether and to what degree maternal NNS ingestion in humans leads to direct in utero exposure.. · This study provides the first evidence of in utero NNS exposure in humans and highlights the urgent need to investigate clinical consequences of early life NNS exposure on metabolism, weight, taste preference, and general health..
本研究旨在通过分析羊水和脐血来探讨人类胎儿对非营养性甜味剂(NNS)的暴露情况。
采用液相色谱-质谱法检测 13 例羊水和 15 例脐血样本中的 4 种 NNS(乙酰磺胺酸钾[ace-K]、糖精、甜菊糖苷葡萄糖醛酸和三氯蔗糖)浓度。羊水样本是在澳大利亚墨尔本 Mercy 医院因择期行足月剖宫产或临床指征行第三孕期羊水减量术而采集,用于研究目的。除 4 名女性外,其余均处于禁食状态。脐血样本来自于另一个队列的新生儿,其母亲参与了美国国立卫生研究院的一项单独临床试验。
13 例羊水样本中有 10 例至少含有一种 NNS(ace-K、糖精、甜菊糖苷葡萄糖醛酸和/或三氯蔗糖)。ace-K、糖精、甜菊糖苷葡萄糖醛酸和三氯蔗糖的最大羊水 NNS 浓度分别为 78.9、55.9、93.5 和 30.6ng/mL。ace-K 和糖精存在于 100%和 80%的脐血样本中,最大浓度分别为 6.5 和 2.7ng/mL。未检测到三氯蔗糖,也无法测量到甜菊糖苷葡萄糖醛酸。
我们的研究结果提供了 NNS 经胎盘转运至胎儿的证据。基于主要来自啮齿动物模型的结果,我们推测 NNS 暴露可能会对后代的代谢健康产生不利影响。需要进行精心设计的前瞻性临床试验,以了解孕期摄入 NNS 对人类发育和长期健康的影响。
· 近年来,孕期 NNS 消费有所增加。· 流行病学研究表明,孕妇在孕期摄入 NNS 与早产和婴儿体重增加有关。· 在啮齿动物中,宫内 NNS 暴露会导致母亲及其后代出现代谢异常,改变后代肠道微生物群组成,并促进成年后对甜味的偏好。· 目前尚不清楚人类母亲在怀孕期间摄入 NNS 是否以及在何种程度上会导致胎儿直接暴露。· 本研究首次提供了人类胎儿宫内 NNS 暴露的证据,并强调迫切需要研究早期生命 NNS 暴露对代谢、体重、味觉偏好和整体健康的临床后果。